Parties collaborating through The Cell Therapy program
Through close cooperation between individuals from industry, academia and investors we are hoping to find new innovative solutions that increase the possibilities of cell therapy all the way to the patient. New collaborations will take the cells to the patient.
The program is supported by Vinnova, Sweden's Innovation Agency.
Karolinska Institutet (KI) is one of the world's leading medical universities.
Develops innovative tools and technologies for commercial cell production – necessary for clinical implementation of cell therapies.
Manufactures and sells biomaterials necessary for the culture and differentiation of specific cells for use in cell therapy.
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB (CPNP) develops new cell-based therapies for treatment of severe diseases.develops new cell-based therapies for treatment of severe diseases.
Mabtech supplies a wide range of antibodies to cytokines, immunoglobulins and apolipoproteins.
Busy developing micro catheter to endovascularly, via a blood vessel, travel to any organ in the body
Former collaborating parties
Manufactures and sells cell culture media for in-vitro fertilization. Develops cell culture media for specific immune cells.